Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel IL-27-based targeting gene therapy shows promise in prostate cancer models

April 22, 2020

Encouraging data reported for Ruconest in patients with COVID-19

April 22, 2020

First patient dosed in global study of low-dose selinexor in severe COVID-19

April 22, 2020

SOM Biotech identifies three drug candidates for COVID-19

April 22, 2020

Researchers find mutated ATP10B to increase risk of Parkinson's disease

April 22, 2020

Fetal pharmacotherapy in the developing inner ear may rescue congenital deafness

April 22, 2020

Narrower interferon activity could benefit immune therapy

April 22, 2020

Modeling the post-infarct heart

April 22, 2020

Depression's structural problem

April 22, 2020

Phase III VANISH-306 study of oral ibrexafungerp in VVC meets primary endpoint

April 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...